Cubist Systematic Strategies’s DICE Therapeutics DICE Stock Holding History
Bought
Maintained
Sold
Cubist Systematic Strategies's DICE Position: Q3 2023 in Review
Cubist Systematic Strategies sold out of DICE Therapeutics (DICE) in Q3 2023, closing a stake of 59,557 shares — an estimated $2.77M sold.
Cubist Systematic Strategies first reported a position in DICE in Q4 2021 and held it in 3 quarters. The position peaked at $2.77M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.
- Cubist Systematic Strategies reported no remaining DICE Therapeutics position as of Q3 2023 after selling out during the quarter.
- Cubist Systematic Strategies sold 59,557 DICE Therapeutics shares in Q3 2023, an estimated $2.77M.
- Cubist Systematic Strategies first reported a position in DICE Therapeutics in Q4 2021 and held it in 3 quarters.
- Cubist Systematic Strategies's DICE Therapeutics position peaked at $2.77M in Q2 2023.
- 0 funds tracked by Wall St. Rank held DICE Therapeutics as of Q3 2023.
Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.